These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7998046

  • 1. [Sumatriptan in the treatment of migraine in general practice].
    Midelfart E, Winnem M.
    Tidsskr Nor Laegeforen; 1994 Nov 30; 114(29):3430-2. PubMed ID: 7998046
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC.
    Curr Med Res Opin; 2005 Oct 30; 21(10):1603-10. PubMed ID: 16238900
    [Abstract] [Full Text] [Related]

  • 6. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.
    Silberstein SD, Mannix LK, Goldstein J, Couch JR, Byrd SC, Ames MH, McDonald SA, Lener SE, Toso C.
    Neurology; 2008 Jul 08; 71(2):114-21. PubMed ID: 18606965
    [Abstract] [Full Text] [Related]

  • 7. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P, Landy S, Richardson M, Ames M.
    Clin Ther; 2005 Nov 08; 27(11):1785-94. PubMed ID: 16368449
    [Abstract] [Full Text] [Related]

  • 8. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr 08; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 9. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA.
    Headache; 2006 Jan 08; 46(1):115-24. PubMed ID: 16412159
    [Abstract] [Full Text] [Related]

  • 10. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan.
    Solbach MP, Waymer RS.
    Obstet Gynecol; 1993 Nov 08; 82(5):769-72. PubMed ID: 8414324
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M.
    Clin Ther; 2007 Jan 08; 29(1):99-109. PubMed ID: 17379050
    [Abstract] [Full Text] [Related]

  • 13. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P, Rothner AD, Wooten JD, Webster C, Ames M.
    Headache; 2006 Feb 08; 46(2):212-22. PubMed ID: 16492230
    [Abstract] [Full Text] [Related]

  • 14. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.
    Headache; 2009 Jul 08; 49(7):971-82. PubMed ID: 19486178
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group.
    Pini LA, Fabbri L, Cavazzuti L.
    Int J Clin Pharmacol Res; 1999 Jul 08; 19(2):57-64. PubMed ID: 10669900
    [Abstract] [Full Text] [Related]

  • 16. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC, Gendolla A, Gebert I, Beneke M.
    Headache; 2005 Jul 08; 45(7):874-82. PubMed ID: 15985104
    [Abstract] [Full Text] [Related]

  • 17. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ, Massiou H, Lainez JM, Cabarrocas X.
    Headache; 2004 Apr 08; 44(4):318-22. PubMed ID: 15109355
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Evaluation of the efficacy of oral sumatriptan in the management of migraine attacks. Clinical results].
    Centonze V, Polito MB, Di Bari M, Fabbri L, Cassiano MA, Bassi A, Albano O.
    Clin Ter; 1995 Nov 08; 146(11):721-8. PubMed ID: 8720348
    [Abstract] [Full Text] [Related]

  • 20. A dose-defining study of sumatriptan suppositories in the acute treatment of migraine.
    Bertin L, Brion N, Färkkilä M, Göbel H, Wessely P.
    Int J Clin Pract; 1999 Dec 08; 53(8):593-8. PubMed ID: 10692752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.